Cargando…

A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis

OBJECTIVE: We conducted a single-centre, randomised, double-blinded, placebo-controlled phase II clinical study to test safety and efficacy of a 12-week therapy with low-dose (700 mg/daily) or high-dose (2800 mg/daily) of NAC. METHODS: Twenty-one patients (ΔF508 homo/heterozygous, FEV(1 )> 40% pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dauletbaev, N, Fischer, P, Aulbach, B, Gross, J, Kusche, W, Thyroff-Friesinger, U, Wagner, TOF, Bargon, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352166/ https://www.ncbi.nlm.nih.gov/pubmed/19666395 http://dx.doi.org/10.1186/2047-783X-14-8-352

Ejemplares similares

High-Dose Ibuprofen in Cystic Fibrosis
por: Lands, Larry C., et al.
Publicado: (2010)

Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults
por: Fey, Constanze, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
por: Reynders, Veerle, et al.
Publicado: (2006)

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
por: Sörgel, Fritz, et al.
Publicado: (2009)

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag)
por: Schapperer, Elisabeth, et al.
Publicado: (2015)

DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine
por: Kiefer, Alexander, et al.
Publicado: (2022)

Effect of N-Acetylcysteine in Combination with Antibiotics on the Biofilms of Three Cystic Fibrosis Pathogens of Emerging Importance
por: Aiyer, Aditi, et al.
Publicado: (2021)

N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review
por: Guerini, Marta, et al.
Publicado: (2022)

Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells
por: Dauletbaev, Nurlan, et al.
Publicado: (2015)

Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
por: Calverley, Peter, et al.
Publicado: (2020)

Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol
por: Luo, Ai, et al.
Publicado: (2022)

The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on Achromobacter xylosoxidans in a Cystic Fibrosis Sputum/Lung Cell Model
por: Aiyer, Aditi, et al.
Publicado: (2022)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

Paracellular Transport through Healthy and Cystic Fibrosis Bronchial Epithelial Cell Lines – Do We Have a Proper Model?
por: Molenda, Natalia, et al.
Publicado: (2014)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
por: Elborn, JS, et al.
Publicado: (2016)

Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
por: Li, Qiyu, et al.
Publicado: (2022)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013)

The Microbiome in Cystic Fibrosis
por: Huang, Yvonne J., et al.
Publicado: (2016)

The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial
por: Liao, Yue, et al.
Publicado: (2022)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
por: Yu, Wencheng, et al.
Publicado: (2016)

538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis
por: Demot, Bernard, et al.
Publicado: (2021)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
por: Bradley, Judy M., et al.
Publicado: (2014)

Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study)
por: Safe, Izabella Picinin, et al.
Publicado: (2020)

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
por: Vázquez-Espinosa, Emma, et al.
Publicado: (2015)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study
por: Papi, Alberto, et al.
Publicado: (2020)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
por: Giam, Beverly, et al.
Publicado: (2017)

N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of mdx Diaphragm
por: Burns, David P., et al.
Publicado: (2019)

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
por: Maghsadi, Zahra, et al.
Publicado: (2023)

Increased levels of anti-glycan antibodies in patients with cystic fibrosis
por: Hirche, TO, et al.
Publicado: (2011)

Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose
por: Duffull, S. B., et al.
Publicado: (2013)

SNAP – A Large Step in the Move towards Personalised Dosing of Acetylcysteine
por: Chiew, Angela L., et al.
Publicado: (2019)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gpl1ctb5o76vfp7v7nmvj6u0v4